SlideShare a Scribd company logo
Topic- Assessment of Drugs
PRESENTED BY PRESENTED TO
NIDHI GOSSAI Dr. DIGVIJAY VERMA
Msc IM IIIrd Sem
CONTENTS
• Introduction
• Recombinant Drugs
• Manufacturing process for recombinant products
• Classification of recombinant products
• Biosafety assessment of drugs
• Hazard identification
• Pharmacopoeia
• Drugs related organizations
• Top 10 pharmaceutical company in world and India
• Ethical issue related to drugs
• Drugs pollution ,sources and effect , prevention
• Drug abusement
• Types of drugs
• International and national organization
What is Drugs
• A drug is any substance that cause a change in an organism physiology or
psychology when consumed.
• A pharmaceutical drug also called a medication or medicine , is a chemical
substances used to treat, cure, prevent or diagnose a disease or to promote well
being.
• WHO define drugs as – any substance or product that is used or intended to be
used to modify or explore physiological systems or pathological state for the
benefit of the recipient.
• Anatomical therapeutic chemical classification system the most widely used drug
classification system assign drugs a unique ATC code which is an Alphanumeric
code that assign it to specific drug classes within the ATC system
• Now a days various human disease are treated with the help of drugs developed
by recombinant technology such as Erythropoietin, coagulation modulator
enzyme, hormone, interferon, interleukins, granulocytes , etc.
• Drugs developed by recombinant technology are known as biologics
biopharmaceuticals recombinant dna expressed products.
Recombinant Drugs
• The recombinant technique was developed by Cohen in 1973.
• The general procedure starts from the identification of the gene responsible for the
production of the desired product. The gene is isolated from human cells and
inserted into other carrier or vector cells like bacteria (Escherichia coli) or yeast
(Saccharomyces cerevisiae, Hansenulla that proliferate and produce large amounts
of the desired product.
• The central theme of recombinant DNA technology is the process of gene cloning
which consists of the production of a defined fragment of DNA and its propagation
and amplification in a suitable host cell.
• Recombinant technology was only possible after the discovery of restriction
endonucleases, the enzymes used as cutters for a desired segment of genes known
as recognition sequences.
• There are various other enzymes that have great value in recombinant technology
such as DNA polymerases, ligases, kinases, alkaline phosphatases, and nucleases.
• [Recombinant technology, thus, is a new method for the development of drugs and
other life-saving products that involves the blending of discoveries in molecular
biology, DNA alteration, gene splicing, immunology, Now a days, various human
diseases are treated with the help of drugs developed by recombinant technology,
such as hepatitis-B vaccine, antibodies erythropoietin, hormones, interferons,
interleukins, granulocyte colony-stimulating factors, anti-rheumatoid drugs etc.
MANUFACTURING PROCESS FOR RECOMBINANT
PRODUCTS
The following steps are involved in the production of
recombinant products
Extraction of the DNA from a donor organism and the plasmid
from bacteria
↓
Cleaved with restriction endonucleases
↓
Joined to form a recombinant DNA molecule or vector
↓
Insert this vector into host cell or expression system (E. coli or
Yeast)
↓
Multiplication of recombinant DNA molecules
↓
Formation of clone
continued
↓
Scale-up (harvesting) of cell to produce recombinant
drugs
↓
Purification (centrifugation or filtration)
↓
Preformulation
↓
Preclinical studies (animal testing)
↓
Clinical studies (human testing)
↓
Final product
CLASSIFICATION OF RECOMBINANT PRODUCTS
• The following products or biologics are obtained by recombinant or genetic engineering
technology:
• (I) Recombinant erythropoietin Epoetin-α Epoetin-β Epoetin-ω
• (II) Recombinant blood coagulation modulators
(a) Coagulants Factor-VII A Factor-VIII Factor-IX
(b) Anticoagulants Lepirudin,Desirudin,Drotecogin
• (III) Recombinant enzyme
(a) Thrombolytic enzymes- Alteplase, Anistreplase, Duteplase, Reteplase Saruplase
. Streptase or streptokinase Tenecteplase Tissue plasminogen activator Urokinase
(b) Therapeutic enzymes - Agalsidase beta Aeromonas aminopeptidase Alpha- .
. glactosidase-A Dornase alpha Imiglucerase or glucocerebrosidase or alglucerase . .
. Laronidase or alpha-L-iduronidase Galsulfase
• (IV) Recombinant hormones
• (a) Insulin and its analogs
Human insulin
Insulin aspart
Insulin glargine
Insulin lispro
Insulin glulisine
Insulin-like growth factor-I
Insulin-like growth factor-II
• (b) Growth hormone and its analogs
Growth hormone
Growth hormone (ovine)
Growth hormone
• (c) Gonadotropins
Recombinant follitropin-α
Recombinant follitropin-β
Recombinant choriogonadotropin
• (V) Recombinant interferons
Interferon alfa-2a
Interferon alfa-2b
Interferon beta-1a
• (VI) Recombinant interleukins
Interleukin-1 alpha
Interleukin-1 beta
• (VII) Recombinant granulocyte colony stimulating
factors
Filgrastim
Lenograstim
Molgramostim
(VIII) Recombinant anti-rheumatoid agents
Inß iximab
Adalimumab
Basiliximab
(IX) Miscellaneous agents
Recombinant antibodies
Recombinant albumin
Chymosin
Endostatin human
Epidermal growth factors
Relaxin
TNF
Recombinant vaccines
Thrombopoietin
Other hormones
Calcitonin
Glucagon
Biosafety Assessment of Drugs
• Biosafety committee
• Biosafety manual
• Biosafety officer
• Biosafety level 2 enhanced or BSL 3
• Biosecurity
• Good manufacturing practices GMP
• Hazard identification
Pharmacopoeia
• It is a book which contains a list of established and officially approved
drugs with description of their physical and chemical characteristics and
test of their identification, purity, and method of storage
• Some of the pharmacopoeia are the Indian Pharmacopoeia BP British
pharmacopoeia EP European P.
• The first p. published in the United states as compiled for army use.
• USP was first published in 1820.
• IP commission is an institution of the Ministry of health and family
welfare which sets standard for all drugs that are manufactured sold
and consumed.
Drugs Related Organizations
• World Health Organizations
• World Bank
• UNICEF( United Nation Children s Fund)
• USAID ( United State Agency for International Development)
• CDC ( Centre for Disease Control and prevention)
• NGO ( Non Governmental Organization)
• NIH ( National Institute of Health)
• NIDA (National Institute on Drug Abuse)
• FDA ( Food and Drug Administration)
• DCGI ( Drug Controller General of India )
• CDCSO (Central Drug Standard Control Organisation)
Top 10 Pharmaceutical company in the World
• Pfizer - USA
• Roche -Swiss pharmaceutical company
• Sanofi -French
• Johnson & Johnson
• Merck & co.(MSD) – America
• Novartis - Switzerland
• Abbvie - America
• Gilead sciences – California
• Glaxo Smith Kline ( GSK) – British
• Amgen - America
Top 10 pharmaceutical company in India
• Aurobindo Pharma ltd. - Hydrabad
• Cadila Healthcare ltd. - Ahemdabad
• Cipla ltd. - Mumbai
• Divis Laboratories ltd. - Hyderabad
• Dr. Reddys Laboratories ltd. - Hyderabad
• Glenmark Pharmaceutical ltd. -Mumbai
• Lupin ltd. -Mumbai
• Sun Pharmaceutical Industries - Mumbai
• Torrent p.ltd.
• Wockhardt ltd - Mumbai
Ethical Issue Related to Drugs
Ethics is a term that can imply lofty (giant), philosophical discussions, far removed from the
everyday world. In reality, workers in the substance abuse treatment field are constantly faced
with ethical dilemmas on an individual as well as a societal level.
Ethics is an intellectual approach to moral issues, a philosophical framework from which to
critically evaluate the choices and actions people take to deal with various aspects of daily living
Working in the substance abuse treatment field presents dilemmas relating to personal beliefs,
judgments, and values.
Ethical Issues for Treatment Providers
The Ethics of HIV/AIDS
HIV/AIDS has its own unique ethical issues. Because HIV can be transmitted through sexual
activity and by sharing drug equipment, it evokes significant personal feelings and judgments in
the general public, as well as in health and social service providers.
Ethics on micro and macro level
Ethical issues are both personal (micro) and societal (macro) in nature. There is an ongoing
struggle between legislating morality for the "public good" and fighting to retain an individual's
right to autonomy. It is the intense emotional nature of such concerns that takes an issue from a
personal level to a societal level.
Balancing Personal and Professional Standards
Alcohol and drug counselors must balance what is right for them personally with what may be
right based on professional standards.
The Need for Staff Training
Basic Ethical Principles
The study of ethics has produced an abundance of writings, and many standards and principles have
been brought forth. However, there are five general principles that provide a firm basis from which to
explore the ethical concerns that arise daily in the substance abuse treatment and HIV/AIDS field
• Justice
• Autonomy
• Beneficence
• Nonmale fiecence
• Fidelity
• Empathy and Excellence
• Honesty
DRUGS POLLUTION
Drug is the pollution of environment with pharmaceutical drugs and
their metabolites which reaches the aquatic environment through
wastewater
SOURCES AND EFFECTS
Most such pollution comes simply from the drugs having been cleared and excreted
In the urine. The portion that comes from expired or unneeded drugs that are flushed
unused down the toilet is smaller but it is also important especially in hospitals.
PREVENTION
The main action for preventing drug pollution is to incinerate unwanted
pharmaceutical drugs. Burning them chemically degrade their active molecule
Another aspect of drug pollution prevention is environmental law and regulation
although it face the problem of enforcement cost enforcement corruption and
negligence.
Drugs Abusement
• Drug abuse is, when you use legal or illegal substances in ways you should
not .
• A pattern of repeated drug or alcohol use that often interfere with health
work or social relationship.
• Commonly used illegal drugs include MARIJUANA , HEROIN
AMPHETAMINES and METHAMPHETAMINES and CLUB DRUGS.
TYPES OF DRUGS
Stimulant e.g. COCAINE
Depressant e.g. ALCOHOL
Opium related painkillers e.g. Heroin
Hallucinogens e.g. LSD
International Organization
• CCSA (Canadian centre on substance abuse)
• ISAM (International society of addiction medicine)
• SSA ( Society for the study of addiction)
• INCASE ( International coalition for addiction)
• IAS ( International AIDS society)
NATIONAL ORGANIZATION
CDCSO ( The central drugs standard control organization)
ADI ( Approve drugs in india)
Refrences
• Copyright Notice
• Bookshelf ID: NBK64933
• https://www.ncbi.nlm.nih.gov/books/NBK64933/
• Nova Scotia. Department of Health Promotion and Protection. (2008). Addiction Services. Available
at: http://www.addictionservices.ns.ca/
• ^ Ontario Public Health Association. (2008). Alcohol Policy Network. Mission. Available
at: http://www.apolnet.ca/aboutus/mission.html
Cohen SN, Chang AC, Boyer HW, Helling RB. Construction of biologically functional bacterial plasmids in vitro. Proc Natl
Acad Sci U S A 1973; 70:3240- 44. 2. Bhopale GM, Nanda RK. Recombinant DNA expression products for human
therapeutic use. Current Science 2005; 89:614-22. 3. Kaplan NP, Colowick NP, Wu R. Recombinant DNA: Recombinant
DNA Part F: Methods in Enzymology. Academic Press;1980. p. 68. 4. Glick BR, Pasternak JJ. Molecular biotechnology,
principles and applications of recombinant DNA. Washington, DC: ASM Press; 1994. p.16-7. 5. Ballington DA, Laughlin
MM. Pharmacology, 3rd ed. New Delhi: CBS Publisher and Distributors; 2008. p. 473-7. 6. Bhopale GM, Nanda RK.
Recombinant human erythropoietin: An overview. Indian Drugs 2004; 41:2707-13.
Topic  assessment of drugs

More Related Content

What's hot

Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animals
pradnya Jagtap
 
Cell culture techniques
Cell culture  techniquesCell culture  techniques
Cell culture techniques
Nivedhitha S
 
Gen bank
Gen bankGen bank
Biotechnology products
Biotechnology productsBiotechnology products
Biotechnology products
Zahra Naz
 
Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animalsBruno Mmassy
 
Cell lines
Cell linesCell lines
Protein micro array
Protein micro arrayProtein micro array
Protein micro array
krupa sagar
 
Recombinant protein
Recombinant proteinRecombinant protein
Recombinant protein
Pranitha Prani
 
Transgenic animal models & their
Transgenic animal models & theirTransgenic animal models & their
Transgenic animal models & their
kalpanatiwari17
 
Third Generation Sequencing
Third Generation Sequencing Third Generation Sequencing
Third Generation Sequencing
priyanka raviraj
 
Cell viability assays
Cell viability assaysCell viability assays
Cell viability assays
Sanju Kaladharan
 
In vitro testing of drug toxicity
In vitro testing of drug toxicityIn vitro testing of drug toxicity
In vitro testing of drug toxicity
Dr Vijayata choudhary
 
Bioentrepreneurship
BioentrepreneurshipBioentrepreneurship
Bioentrepreneurship
Benish
 
Dna microarray (dna chips)
Dna microarray (dna chips)Dna microarray (dna chips)
Dna microarray (dna chips)Rachana Tiwari
 
Microbial production of L-Asparaginase
Microbial production of L-Asparaginase Microbial production of L-Asparaginase
Microbial production of L-Asparaginase
SuhasRathnakar
 
Animal models for disease analysis
Animal models for disease analysisAnimal models for disease analysis
Animal models for disease analysis
Bahauddin Zakariya University lahore
 
Biosafety guidelines
Biosafety guidelinesBiosafety guidelines
Biosafety guidelines
Aakilasahul3010
 
Cytotoxicity
CytotoxicityCytotoxicity
Cytotoxicity
Haroon Khaliq
 
Transgenic Animals
Transgenic AnimalsTransgenic Animals
Transgenic Animals
prachidixit23
 

What's hot (20)

Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animals
 
Cell culture techniques
Cell culture  techniquesCell culture  techniques
Cell culture techniques
 
Gen bank
Gen bankGen bank
Gen bank
 
Biotechnology products
Biotechnology productsBiotechnology products
Biotechnology products
 
Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animals
 
Cell lines
Cell linesCell lines
Cell lines
 
Protein micro array
Protein micro arrayProtein micro array
Protein micro array
 
Recombinant protein
Recombinant proteinRecombinant protein
Recombinant protein
 
Transgenic animal models & their
Transgenic animal models & theirTransgenic animal models & their
Transgenic animal models & their
 
Third Generation Sequencing
Third Generation Sequencing Third Generation Sequencing
Third Generation Sequencing
 
Cell viability assays
Cell viability assaysCell viability assays
Cell viability assays
 
In vitro testing of drug toxicity
In vitro testing of drug toxicityIn vitro testing of drug toxicity
In vitro testing of drug toxicity
 
Bioentrepreneurship
BioentrepreneurshipBioentrepreneurship
Bioentrepreneurship
 
Dna microarray (dna chips)
Dna microarray (dna chips)Dna microarray (dna chips)
Dna microarray (dna chips)
 
Microbial production of L-Asparaginase
Microbial production of L-Asparaginase Microbial production of L-Asparaginase
Microbial production of L-Asparaginase
 
Biotech industry
Biotech industry Biotech industry
Biotech industry
 
Animal models for disease analysis
Animal models for disease analysisAnimal models for disease analysis
Animal models for disease analysis
 
Biosafety guidelines
Biosafety guidelinesBiosafety guidelines
Biosafety guidelines
 
Cytotoxicity
CytotoxicityCytotoxicity
Cytotoxicity
 
Transgenic Animals
Transgenic AnimalsTransgenic Animals
Transgenic Animals
 

Similar to Topic assessment of drugs

Biosimilars
BiosimilarsBiosimilars
Biosimilars
Dineshk117
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drugswati2084
 
An overview of the Pharmaceutical Industry
An overview of the Pharmaceutical Industry An overview of the Pharmaceutical Industry
An overview of the Pharmaceutical Industry
UNIVERSITI MALAYSIA SABAH
 
PHARMACOVIGILANCE & PHYTO RESEARCH
 PHARMACOVIGILANCE & PHYTO RESEARCH PHARMACOVIGILANCE & PHYTO RESEARCH
PHARMACOVIGILANCE & PHYTO RESEARCH
Shivaji University
 
Drud Discovery - Dr. Amsavel.pdf
Drud Discovery -  Dr. Amsavel.pdfDrud Discovery -  Dr. Amsavel.pdf
Drud Discovery - Dr. Amsavel.pdf
Dr. Amsavel A
 
FDA Presentation on Biologics
FDA Presentation on BiologicsFDA Presentation on Biologics
FDA Presentation on Biologics
Robert Puopolo
 
Reverse Pharmacology
Reverse PharmacologyReverse Pharmacology
Reverse Pharmacology
Dr. Ashutosh Tiwari
 
Drug discovery
Drug discoveryDrug discovery
Drug discovery
Saba Ahmed
 
drug research.pptx
drug research.pptxdrug research.pptx
drug research.pptx
VdJani
 
Drug development prodrug PhD seminar mehdi akhlaghi
Drug development  prodrug PhD seminar mehdi akhlaghiDrug development  prodrug PhD seminar mehdi akhlaghi
Drug development prodrug PhD seminar mehdi akhlaghi
Mehdi Akhlaghi
 
USFDA NDA Vs BLA
USFDA NDA Vs BLAUSFDA NDA Vs BLA
USFDA NDA Vs BLA
Girish Swami
 
Pharmacy Orientation----------(Pharmaceutics)
Pharmacy Orientation----------(Pharmaceutics)Pharmacy Orientation----------(Pharmaceutics)
Pharmacy Orientation----------(Pharmaceutics)
Soft-Learners
 
Medicinal chemistry unit1&3
Medicinal chemistry unit1&3Medicinal chemistry unit1&3
Medicinal chemistry unit1&3
bvocmithilesh
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
chandiniyrao
 
Biosimilars.pdf
Biosimilars.pdfBiosimilars.pdf
Biosimilars.pdf
Ravi890348
 
Biopharmaceutical Products, GMP, Manufacturing Facilities for Biopharmaceuticals
Biopharmaceutical Products, GMP, Manufacturing Facilities for BiopharmaceuticalsBiopharmaceutical Products, GMP, Manufacturing Facilities for Biopharmaceuticals
Biopharmaceutical Products, GMP, Manufacturing Facilities for Biopharmaceuticals
Tanvi Potluri
 
Drug Discovery And Development
Drug Discovery And Development Drug Discovery And Development
Drug Discovery And Development
AyushTripathi69
 
Pharmacology basic concept
Pharmacology basic conceptPharmacology basic concept
Pharmacology basic concept
Dr Vinay Gupta
 
concept of biosimilars
concept of biosimilarsconcept of biosimilars
concept of biosimilars
kkoberoi
 

Similar to Topic assessment of drugs (20)

Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drug
 
An overview of the Pharmaceutical Industry
An overview of the Pharmaceutical Industry An overview of the Pharmaceutical Industry
An overview of the Pharmaceutical Industry
 
PHARMACOVIGILANCE & PHYTO RESEARCH
 PHARMACOVIGILANCE & PHYTO RESEARCH PHARMACOVIGILANCE & PHYTO RESEARCH
PHARMACOVIGILANCE & PHYTO RESEARCH
 
Drud Discovery - Dr. Amsavel.pdf
Drud Discovery -  Dr. Amsavel.pdfDrud Discovery -  Dr. Amsavel.pdf
Drud Discovery - Dr. Amsavel.pdf
 
Biotech chapter 1
Biotech chapter 1Biotech chapter 1
Biotech chapter 1
 
FDA Presentation on Biologics
FDA Presentation on BiologicsFDA Presentation on Biologics
FDA Presentation on Biologics
 
Reverse Pharmacology
Reverse PharmacologyReverse Pharmacology
Reverse Pharmacology
 
Drug discovery
Drug discoveryDrug discovery
Drug discovery
 
drug research.pptx
drug research.pptxdrug research.pptx
drug research.pptx
 
Drug development prodrug PhD seminar mehdi akhlaghi
Drug development  prodrug PhD seminar mehdi akhlaghiDrug development  prodrug PhD seminar mehdi akhlaghi
Drug development prodrug PhD seminar mehdi akhlaghi
 
USFDA NDA Vs BLA
USFDA NDA Vs BLAUSFDA NDA Vs BLA
USFDA NDA Vs BLA
 
Pharmacy Orientation----------(Pharmaceutics)
Pharmacy Orientation----------(Pharmaceutics)Pharmacy Orientation----------(Pharmaceutics)
Pharmacy Orientation----------(Pharmaceutics)
 
Medicinal chemistry unit1&3
Medicinal chemistry unit1&3Medicinal chemistry unit1&3
Medicinal chemistry unit1&3
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
Biosimilars.pdf
Biosimilars.pdfBiosimilars.pdf
Biosimilars.pdf
 
Biopharmaceutical Products, GMP, Manufacturing Facilities for Biopharmaceuticals
Biopharmaceutical Products, GMP, Manufacturing Facilities for BiopharmaceuticalsBiopharmaceutical Products, GMP, Manufacturing Facilities for Biopharmaceuticals
Biopharmaceutical Products, GMP, Manufacturing Facilities for Biopharmaceuticals
 
Drug Discovery And Development
Drug Discovery And Development Drug Discovery And Development
Drug Discovery And Development
 
Pharmacology basic concept
Pharmacology basic conceptPharmacology basic concept
Pharmacology basic concept
 
concept of biosimilars
concept of biosimilarsconcept of biosimilars
concept of biosimilars
 

More from NidhiGossai

Chi square test
Chi square testChi square test
Chi square test
NidhiGossai
 
Presentation1 nidhi copy - copy
Presentation1 nidhi   copy - copyPresentation1 nidhi   copy - copy
Presentation1 nidhi copy - copy
NidhiGossai
 
Biosynthesis of purines and pyrimidines new
Biosynthesis of purines and pyrimidines newBiosynthesis of purines and pyrimidines new
Biosynthesis of purines and pyrimidines new
NidhiGossai
 
Biosensors
BiosensorsBiosensors
Biosensors
NidhiGossai
 
Bacterial recombination and DNA repair
Bacterial recombination and DNA repairBacterial recombination and DNA repair
Bacterial recombination and DNA repair
NidhiGossai
 
Insulin
InsulinInsulin
Insulin
NidhiGossai
 
VACCINES
VACCINESVACCINES
VACCINES
NidhiGossai
 
Topic vitamin a
Topic  vitamin aTopic  vitamin a
Topic vitamin a
NidhiGossai
 

More from NidhiGossai (8)

Chi square test
Chi square testChi square test
Chi square test
 
Presentation1 nidhi copy - copy
Presentation1 nidhi   copy - copyPresentation1 nidhi   copy - copy
Presentation1 nidhi copy - copy
 
Biosynthesis of purines and pyrimidines new
Biosynthesis of purines and pyrimidines newBiosynthesis of purines and pyrimidines new
Biosynthesis of purines and pyrimidines new
 
Biosensors
BiosensorsBiosensors
Biosensors
 
Bacterial recombination and DNA repair
Bacterial recombination and DNA repairBacterial recombination and DNA repair
Bacterial recombination and DNA repair
 
Insulin
InsulinInsulin
Insulin
 
VACCINES
VACCINESVACCINES
VACCINES
 
Topic vitamin a
Topic  vitamin aTopic  vitamin a
Topic vitamin a
 

Recently uploaded

Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
NathanBaughman3
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
ssuserbfdca9
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
IqrimaNabilatulhusni
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
muralinath2
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
Sérgio Sacani
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
kumarmathi863
 

Recently uploaded (20)

Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 

Topic assessment of drugs

  • 1. Topic- Assessment of Drugs PRESENTED BY PRESENTED TO NIDHI GOSSAI Dr. DIGVIJAY VERMA Msc IM IIIrd Sem
  • 2. CONTENTS • Introduction • Recombinant Drugs • Manufacturing process for recombinant products • Classification of recombinant products • Biosafety assessment of drugs • Hazard identification • Pharmacopoeia • Drugs related organizations • Top 10 pharmaceutical company in world and India • Ethical issue related to drugs • Drugs pollution ,sources and effect , prevention • Drug abusement • Types of drugs • International and national organization
  • 3. What is Drugs • A drug is any substance that cause a change in an organism physiology or psychology when consumed. • A pharmaceutical drug also called a medication or medicine , is a chemical substances used to treat, cure, prevent or diagnose a disease or to promote well being. • WHO define drugs as – any substance or product that is used or intended to be used to modify or explore physiological systems or pathological state for the benefit of the recipient. • Anatomical therapeutic chemical classification system the most widely used drug classification system assign drugs a unique ATC code which is an Alphanumeric code that assign it to specific drug classes within the ATC system • Now a days various human disease are treated with the help of drugs developed by recombinant technology such as Erythropoietin, coagulation modulator enzyme, hormone, interferon, interleukins, granulocytes , etc. • Drugs developed by recombinant technology are known as biologics biopharmaceuticals recombinant dna expressed products.
  • 4. Recombinant Drugs • The recombinant technique was developed by Cohen in 1973. • The general procedure starts from the identification of the gene responsible for the production of the desired product. The gene is isolated from human cells and inserted into other carrier or vector cells like bacteria (Escherichia coli) or yeast (Saccharomyces cerevisiae, Hansenulla that proliferate and produce large amounts of the desired product. • The central theme of recombinant DNA technology is the process of gene cloning which consists of the production of a defined fragment of DNA and its propagation and amplification in a suitable host cell. • Recombinant technology was only possible after the discovery of restriction endonucleases, the enzymes used as cutters for a desired segment of genes known as recognition sequences. • There are various other enzymes that have great value in recombinant technology such as DNA polymerases, ligases, kinases, alkaline phosphatases, and nucleases. • [Recombinant technology, thus, is a new method for the development of drugs and other life-saving products that involves the blending of discoveries in molecular biology, DNA alteration, gene splicing, immunology, Now a days, various human diseases are treated with the help of drugs developed by recombinant technology, such as hepatitis-B vaccine, antibodies erythropoietin, hormones, interferons, interleukins, granulocyte colony-stimulating factors, anti-rheumatoid drugs etc.
  • 5. MANUFACTURING PROCESS FOR RECOMBINANT PRODUCTS The following steps are involved in the production of recombinant products Extraction of the DNA from a donor organism and the plasmid from bacteria ↓ Cleaved with restriction endonucleases ↓ Joined to form a recombinant DNA molecule or vector ↓ Insert this vector into host cell or expression system (E. coli or Yeast) ↓ Multiplication of recombinant DNA molecules ↓ Formation of clone
  • 6. continued ↓ Scale-up (harvesting) of cell to produce recombinant drugs ↓ Purification (centrifugation or filtration) ↓ Preformulation ↓ Preclinical studies (animal testing) ↓ Clinical studies (human testing) ↓ Final product
  • 7. CLASSIFICATION OF RECOMBINANT PRODUCTS • The following products or biologics are obtained by recombinant or genetic engineering technology: • (I) Recombinant erythropoietin Epoetin-α Epoetin-β Epoetin-ω • (II) Recombinant blood coagulation modulators (a) Coagulants Factor-VII A Factor-VIII Factor-IX (b) Anticoagulants Lepirudin,Desirudin,Drotecogin • (III) Recombinant enzyme (a) Thrombolytic enzymes- Alteplase, Anistreplase, Duteplase, Reteplase Saruplase . Streptase or streptokinase Tenecteplase Tissue plasminogen activator Urokinase (b) Therapeutic enzymes - Agalsidase beta Aeromonas aminopeptidase Alpha- . . glactosidase-A Dornase alpha Imiglucerase or glucocerebrosidase or alglucerase . . . Laronidase or alpha-L-iduronidase Galsulfase • (IV) Recombinant hormones
  • 8. • (a) Insulin and its analogs Human insulin Insulin aspart Insulin glargine Insulin lispro Insulin glulisine Insulin-like growth factor-I Insulin-like growth factor-II • (b) Growth hormone and its analogs Growth hormone Growth hormone (ovine) Growth hormone • (c) Gonadotropins Recombinant follitropin-α Recombinant follitropin-β Recombinant choriogonadotropin
  • 9. • (V) Recombinant interferons Interferon alfa-2a Interferon alfa-2b Interferon beta-1a • (VI) Recombinant interleukins Interleukin-1 alpha Interleukin-1 beta • (VII) Recombinant granulocyte colony stimulating factors Filgrastim Lenograstim Molgramostim (VIII) Recombinant anti-rheumatoid agents Inß iximab Adalimumab Basiliximab (IX) Miscellaneous agents Recombinant antibodies Recombinant albumin Chymosin Endostatin human Epidermal growth factors Relaxin TNF Recombinant vaccines Thrombopoietin Other hormones Calcitonin Glucagon
  • 10. Biosafety Assessment of Drugs • Biosafety committee • Biosafety manual • Biosafety officer • Biosafety level 2 enhanced or BSL 3 • Biosecurity • Good manufacturing practices GMP • Hazard identification
  • 11. Pharmacopoeia • It is a book which contains a list of established and officially approved drugs with description of their physical and chemical characteristics and test of their identification, purity, and method of storage • Some of the pharmacopoeia are the Indian Pharmacopoeia BP British pharmacopoeia EP European P. • The first p. published in the United states as compiled for army use. • USP was first published in 1820. • IP commission is an institution of the Ministry of health and family welfare which sets standard for all drugs that are manufactured sold and consumed.
  • 12. Drugs Related Organizations • World Health Organizations • World Bank • UNICEF( United Nation Children s Fund) • USAID ( United State Agency for International Development) • CDC ( Centre for Disease Control and prevention) • NGO ( Non Governmental Organization) • NIH ( National Institute of Health) • NIDA (National Institute on Drug Abuse) • FDA ( Food and Drug Administration) • DCGI ( Drug Controller General of India ) • CDCSO (Central Drug Standard Control Organisation)
  • 13. Top 10 Pharmaceutical company in the World • Pfizer - USA • Roche -Swiss pharmaceutical company • Sanofi -French • Johnson & Johnson • Merck & co.(MSD) – America • Novartis - Switzerland • Abbvie - America • Gilead sciences – California • Glaxo Smith Kline ( GSK) – British • Amgen - America
  • 14. Top 10 pharmaceutical company in India • Aurobindo Pharma ltd. - Hydrabad • Cadila Healthcare ltd. - Ahemdabad • Cipla ltd. - Mumbai • Divis Laboratories ltd. - Hyderabad • Dr. Reddys Laboratories ltd. - Hyderabad • Glenmark Pharmaceutical ltd. -Mumbai • Lupin ltd. -Mumbai • Sun Pharmaceutical Industries - Mumbai • Torrent p.ltd. • Wockhardt ltd - Mumbai
  • 15. Ethical Issue Related to Drugs Ethics is a term that can imply lofty (giant), philosophical discussions, far removed from the everyday world. In reality, workers in the substance abuse treatment field are constantly faced with ethical dilemmas on an individual as well as a societal level. Ethics is an intellectual approach to moral issues, a philosophical framework from which to critically evaluate the choices and actions people take to deal with various aspects of daily living Working in the substance abuse treatment field presents dilemmas relating to personal beliefs, judgments, and values. Ethical Issues for Treatment Providers The Ethics of HIV/AIDS HIV/AIDS has its own unique ethical issues. Because HIV can be transmitted through sexual activity and by sharing drug equipment, it evokes significant personal feelings and judgments in the general public, as well as in health and social service providers.
  • 16. Ethics on micro and macro level Ethical issues are both personal (micro) and societal (macro) in nature. There is an ongoing struggle between legislating morality for the "public good" and fighting to retain an individual's right to autonomy. It is the intense emotional nature of such concerns that takes an issue from a personal level to a societal level. Balancing Personal and Professional Standards Alcohol and drug counselors must balance what is right for them personally with what may be right based on professional standards. The Need for Staff Training Basic Ethical Principles The study of ethics has produced an abundance of writings, and many standards and principles have been brought forth. However, there are five general principles that provide a firm basis from which to explore the ethical concerns that arise daily in the substance abuse treatment and HIV/AIDS field
  • 17. • Justice • Autonomy • Beneficence • Nonmale fiecence • Fidelity • Empathy and Excellence • Honesty DRUGS POLLUTION Drug is the pollution of environment with pharmaceutical drugs and their metabolites which reaches the aquatic environment through wastewater
  • 18. SOURCES AND EFFECTS Most such pollution comes simply from the drugs having been cleared and excreted In the urine. The portion that comes from expired or unneeded drugs that are flushed unused down the toilet is smaller but it is also important especially in hospitals. PREVENTION The main action for preventing drug pollution is to incinerate unwanted pharmaceutical drugs. Burning them chemically degrade their active molecule Another aspect of drug pollution prevention is environmental law and regulation although it face the problem of enforcement cost enforcement corruption and negligence.
  • 19. Drugs Abusement • Drug abuse is, when you use legal or illegal substances in ways you should not . • A pattern of repeated drug or alcohol use that often interfere with health work or social relationship. • Commonly used illegal drugs include MARIJUANA , HEROIN AMPHETAMINES and METHAMPHETAMINES and CLUB DRUGS. TYPES OF DRUGS Stimulant e.g. COCAINE Depressant e.g. ALCOHOL Opium related painkillers e.g. Heroin Hallucinogens e.g. LSD
  • 20. International Organization • CCSA (Canadian centre on substance abuse) • ISAM (International society of addiction medicine) • SSA ( Society for the study of addiction) • INCASE ( International coalition for addiction) • IAS ( International AIDS society) NATIONAL ORGANIZATION CDCSO ( The central drugs standard control organization) ADI ( Approve drugs in india)
  • 21. Refrences • Copyright Notice • Bookshelf ID: NBK64933 • https://www.ncbi.nlm.nih.gov/books/NBK64933/ • Nova Scotia. Department of Health Promotion and Protection. (2008). Addiction Services. Available at: http://www.addictionservices.ns.ca/ • ^ Ontario Public Health Association. (2008). Alcohol Policy Network. Mission. Available at: http://www.apolnet.ca/aboutus/mission.html Cohen SN, Chang AC, Boyer HW, Helling RB. Construction of biologically functional bacterial plasmids in vitro. Proc Natl Acad Sci U S A 1973; 70:3240- 44. 2. Bhopale GM, Nanda RK. Recombinant DNA expression products for human therapeutic use. Current Science 2005; 89:614-22. 3. Kaplan NP, Colowick NP, Wu R. Recombinant DNA: Recombinant DNA Part F: Methods in Enzymology. Academic Press;1980. p. 68. 4. Glick BR, Pasternak JJ. Molecular biotechnology, principles and applications of recombinant DNA. Washington, DC: ASM Press; 1994. p.16-7. 5. Ballington DA, Laughlin MM. Pharmacology, 3rd ed. New Delhi: CBS Publisher and Distributors; 2008. p. 473-7. 6. Bhopale GM, Nanda RK. Recombinant human erythropoietin: An overview. Indian Drugs 2004; 41:2707-13.